WO1988007080A3 - Cellules animales transgeniques resistantes aux infections virales - Google Patents

Cellules animales transgeniques resistantes aux infections virales Download PDF

Info

Publication number
WO1988007080A3
WO1988007080A3 PCT/US1988/000491 US8800491W WO8807080A3 WO 1988007080 A3 WO1988007080 A3 WO 1988007080A3 US 8800491 W US8800491 W US 8800491W WO 8807080 A3 WO8807080 A3 WO 8807080A3
Authority
WO
WIPO (PCT)
Prior art keywords
animal cells
viral infection
transgenic animal
cells resistant
resistant
Prior art date
Application number
PCT/US1988/000491
Other languages
English (en)
Other versions
WO1988007080A2 (fr
Inventor
Erik A Petrovskis
Leonard E Post
Original Assignee
Upjohn Co
Erik A Petrovskis
Leonard E Post
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co, Erik A Petrovskis, Leonard E Post filed Critical Upjohn Co
Publication of WO1988007080A2 publication Critical patent/WO1988007080A2/fr
Publication of WO1988007080A3 publication Critical patent/WO1988007080A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/108—Swine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/02—Animal zootechnically ameliorated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Des procédés servent à produire des cellules animales résistantes aux infections virales. En particulier, des cellules animales transformées par la glycoprotéine gp50 de codage des gènes du virus de la pseudo-rage résistent aux infections par des virus de l'herpès, en particulier le virus de l'herpes simplex et le virus de la pseudo-rage.
PCT/US1988/000491 1987-03-09 1988-02-26 Cellules animales transgeniques resistantes aux infections virales WO1988007080A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2340187A 1987-03-09 1987-03-09
US023,401 1987-03-09

Publications (2)

Publication Number Publication Date
WO1988007080A2 WO1988007080A2 (fr) 1988-09-22
WO1988007080A3 true WO1988007080A3 (fr) 1988-11-03

Family

ID=21814864

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1988/000491 WO1988007080A2 (fr) 1987-03-09 1988-02-26 Cellules animales transgeniques resistantes aux infections virales

Country Status (4)

Country Link
EP (1) EP0354213A1 (fr)
JP (1) JPH02502425A (fr)
AU (1) AU616211B2 (fr)
WO (1) WO1988007080A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989005349A1 (fr) * 1987-12-09 1989-06-15 The Australian National University Procede servant a combattre des infections virales
NL8901651A (nl) * 1989-06-29 1991-01-16 Centraal Diergeneeskundig Inst Vaccin tegen pestivirusinfecties, zoals varkenspest; daarvoor bruikbare nucleotidesequenties en polypeptiden.
FR2655855B1 (fr) * 1989-12-20 1992-04-10 Pasteur Institut Protection genetique d'animaux contre l'infection par le virus leucemogene bovin, et provirus et virus recombinant derive de ce virus.
GB9520641D0 (en) * 1995-10-10 1995-12-13 Medical Res Council Improvements in or relating to protection against intracellular infection
IL123411A0 (en) * 1998-02-22 1998-09-24 Kimron Veterinary Inst High efficiency methods and compositions for integrating exogenous dna into genomic dna of sperm

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986005516A1 (fr) * 1985-03-21 1986-09-25 Duke University Resistance derivee d'un parasite
WO1987002058A1 (fr) * 1985-10-04 1987-04-09 The Upjohn Company Proteine du virus pseudorabique

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0351418B1 (fr) * 1987-03-19 1995-05-17 Synergen, Inc. Systeme de vecteur viral pour l'introduction de produits exprimant un adn etranger chez les volailles gallinacees
EP0364492A1 (fr) * 1987-06-30 1990-04-25 The Upjohn Company Proteines virales presentant une glycosylation a liaison o reduite
ZA886518B (en) * 1987-09-03 1989-05-30 Commw Scient Ind Res Org Coal ash modification and reduction

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986005516A1 (fr) * 1985-03-21 1986-09-25 Duke University Resistance derivee d'un parasite
WO1987002058A1 (fr) * 1985-10-04 1987-04-09 The Upjohn Company Proteine du virus pseudorabique

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Cell, vol. 27, November 1981 R.L. Brinster et al.: "Somatic expression of herpes thymidine kinase in mice following injection of a fusion gene into eggs" pages 223-231 *
Journal of Virology, vol. 59, no. 2, August 1986, American Soc. for Microbiology, US; E.A. Petrovskis et al.: "DNA sequence of the gene for Pseudorabies virus gp50, a glycoprotein without N-linked glycosylation", pages 216-223 *
Science, vol. 229, 26th July 1985 J.G. Izant et al.: "Constitutive and conditional suppression of exogenous and endogenous genes by anti-sense RNA" pages 345-352 *

Also Published As

Publication number Publication date
EP0354213A1 (fr) 1990-02-14
AU616211B2 (en) 1991-10-24
JPH02502425A (ja) 1990-08-09
AU2380088A (en) 1988-10-10
WO1988007080A2 (fr) 1988-09-22

Similar Documents

Publication Publication Date Title
EP0370458A3 (fr) Antigènes à partir d'ADN synthétique dérivé du virus de l'immunodéficience humaine (HIV-1) recombinant
PH25689A (en) Materials, methods for herpes simplex virus vaccination
EP0595436A3 (fr) Virus du syndrÔme disgènésique respiratoire et de reproduction porcin, vaccins et ADN virol.
AU2234995A (en) Feline immunodeficiency virus vaccine
EP0332677A4 (en) Attenuated herpes viruses, herpes viruses which include foreign dna encoding an amino acid sequence and vaccines containing same
EP0179139A4 (fr) Analyse, vaccin et immunogene du virus associe a la leucemie.
EP0241239A3 (en) A cell line producing aids viral antigens without producing infectious virus particles
CA2186044A1 (fr) Nouveaux virus mutes, composes antiviraux et nouveaux procedes de production de vaccins
IL77694A (en) Canine parvovirus vaccines comprising viruses of the canine parvovirus strain 154 or viruses derived therefrom by additional cell culture passaging
CA2130360A1 (fr) Derives de l'acide sulfonique pour le traitement des maladies virales
AU7234987A (en) Viral vector coding for a glycoprotein of the virus responsible for a.i.d.s., vaccine and antibody
AU6790087A (en) Modification of plant viruses or their effects
AU634289B2 (en) A multifunctional rna having self-processing activity, the preparation thereof and the use thereof
DK333083D0 (da) 2-aza-bicyclo(2.2.2)octan-3-carboxylsyrederivater, deres fremstilling og anvendelse samt ved fremstillingen anvendelige mellemprodukter og disses fremstilling
ES529225A0 (es) Un procedimiento para preparar un organismo unicelular que tiene una secuencia de adn que codifica un plipeptid0 que tiene un determinante inmunorreactivo u antigeno de una glicoproteina de virus de herpes simplex.
WO1988007080A3 (fr) Cellules animales transgeniques resistantes aux infections virales
AU1745283A (en) Herpes antigen from engineered e.coli
GR3032767T3 (en) Equine herpes viruses (EHV) containing foreign DNA, process for their preparation and their use as vaccines.
CA2245545A1 (fr) Produit vaccinal issu du gene 63 actif contre le virus varicelle-zona
EP0245456A4 (fr) Expresion du gene du virus du sida.
WO1990013281A3 (fr) Procede de suppression d'une infection par l'hiv
AU2833789A (en) Non-reverting rna viruses
AU7514087A (en) Vaccine containing the protein f of the aids virus
AU2190288A (en) Vector for the expression of proteins of the HIV-2 virus, one of the casual agents of AIDS, cell culture infected or transformed by this vector, proteins obtained, vaccine and antibodies obtained
AU4070289A (en) Monoclonal antibody for inhibiting cell infection by hiv viruses

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU DK FI JP KR NO US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LU NL SE

AK Designated states

Kind code of ref document: A3

Designated state(s): AU DK FI JP KR NO US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE FR GB IT LU NL SE

WWE Wipo information: entry into national phase

Ref document number: 1988903487

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1988903487

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1988903487

Country of ref document: EP